COVID-19 | Specialty

The Good, the Bad, and the Ugly: Academic Medicine in the Spotlight

July 29th 2020

The coronavirus disease 2019 pandemic has raised the public profile of experts in infectious disease, epidemiology, and public health.

Duvelisib May Reduce Lung Inflammation in Severe COVID-19 Cases

July 27th 2020

An Emory University-led phase 2 study will evaluate whether the the PI3K-gamma/delta inhibitor duvelisib is effective at reducing lung inflammation in patients with severe novel coronavirus 2019, thereby decreasing incidences of mechanical ventilation and death in these patients.

CDC Adds Cancer to List of Underlying Medical Conditions That May Result in Severe COVID-19

July 27th 2020

Following a recent update from the Centers for Disease Control and Prevention, cancer has been added to the list of underlying medical conditions that may result in a more severe case of novel coronavirus 2019 should exposure to the virus occur.

CCC-19 Registry Data Show Increased COVID-19–Associated Mortality in Patients With Cancer

July 22nd 2020

The mortality rate with COVID-19 appears to be higher in patients with cancer—especially those with lung cancer—compared with the general population, and several factors associated with mortality are beginning to emerge.

Tocilizumab Does Not Inhibit Antibody Response to SARS-CoV-2

July 22nd 2020

Treatment with tocilizumab does not appear to inhibit the induction of anti-SARS-CoV-2 antibodies in patients with severe coronavirus disease 2019.

COVID-19 Is More Than the Common Cold: Fauci Calls for Perpetual Preparation

July 20th 2020

The situation with the coronavirus-19 pandemic continues to rapidly evolve, but one thing is clear: this is much more than just the common cold.

Immunotherapy Use Does Not Correlate With Increased Mortality in Patients with COVID-19, Cancer

July 20th 2020

Treatment with immune checkpoint inhibitors did not increase the risk of mortality in patients with COVID-19 and cancer.

NCI Awards Funding to Sidney Kimmel Cancer Center - Jefferson Health to Assess Impact of Telehealth During COVID-19 Pandemic

July 20th 2020

The National Cancer Institute has awarded the Sidney Kimmel Cancer Center – Jefferson Health a supplemental grant to study the role of telehealth in delivering cancer care during the COVID-19 pandemic.

Sam Shares Strategies for Providing Optimal Care to Geriatric Patients With Cancer During the COVID-19 Crisis

July 14th 2020

Christine Sam, MD, discusses strategies to prevent the spread of COVID-19 in geriatric patients with cancer and shared advice on how to overcome unique challenges faced in the care of this population.

Early Data Suggest Acalabrutinib May Benefit Patients With Advanced COVID-19

July 14th 2020

Treatment with the BTK inhibitor acalabrutinib resulted in decreased inflammation and improve outcomes in patients with severe coronavirus disease 2019.

Survey Indicates Urgent Need For COVID-19 Testing in Vulnerable Patients With Kidney Cancer

July 9th 2020

Only a small percentage of patients with kidney cancer who are considered to be particularly vulnerable to COVID-19 have actually been tested for infection.

COVID-19 Blood Clotting Cause Identified in Study Led by Yale Cancer Center Researchers

July 8th 2020

One of the major mysteries in treating patients with COVID-19 is the frequent development of blood clots that can subsequently damage their organs and sometimes be fatal.

Dexamethasone: A Potential Gamechanger in the Fight Against COVID-19?

July 8th 2020

Research efforts have revealed a potential weapon to add to the treatment arsenal against COVID-19, a drug that has historically played a crucial role in oncology treatment: the inexpensive, and widely accessible, corticosteroid dexamethasone.

Exploring CAR T-Cell Therapy During COVID-19: What’s on the Horizon for CAR T-Cell Therapy

July 3rd 2020

Exploring CAR T-Cell Therapy During the COVID-19 Pandemic: Mitigation and Management of Adverse Events

July 3rd 2020

Exploring CAR T-Cell Therapy During the COVID-19 Pandemic: A Closer Look at Real-World Data

July 3rd 2020

Exploring CAR T-Cell Therapy During The COVID-19 Pandemic

July 3rd 2020

Dr. Abid on the Impact of the COVID-19 Pandemic on Patients With Cancer

July 2nd 2020

Muhammad Bilal Abid, MD, MRCP, discusses the current coronavirus disease 2019 pandemic and its clinical impact on patients with cancer.

St. Jude Launches Pediatric Global COVID-19 Observatory and Resource Center

June 28th 2020

Following the arrival of the coronavirus disease 2019 pandemic, St. Jude Children's Research Hospital launched the first Global COVID-19 Observatory and Resource Center for Childhood Cancer.

Contemporary Considerations for Cancer Care in the COVID-19 Era

June 26th 2020

The downstream effects of the coronavirus disease 2019 on patients with cancer have become apparent over the past few months, and the onus is on the field to provide clinical guidance on best practices in the absence of definitive data.